BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 10675236)

  • 1. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.
    Lord RV; Salonga D; Danenberg KD; Peters JH; DeMeester TR; Park JM; Johansson J; Skinner KA; Chandrasoma P; DeMeester SR; Bremner CG; Tsai PI; Danenberg PV
    J Gastrointest Surg; 2000; 4(2):135-42. PubMed ID: 10675236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma.
    Barclay JY; Morris A; Nwokolo CU
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):221-7. PubMed ID: 15674101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Brabender J; Lord RV; Danenberg KD; Metzger R; Schneider PM; Park JM; Salonga D; Groshen S; Tsao-Wei DD; DeMeester TR; Hölscher AH; Danenberg PV
    J Surg Res; 2001 Aug; 99(2):301-6. PubMed ID: 11469901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence.
    Lord RV; Tsai PI; Danenberg KD; Peters JH; Demeester TR; Tsao-Wei DD; Groshen S; Salonga D; Park JM; Crookes PF; Kiyabu M; Chandrasoma P; Danenberg PV
    Surgery; 2001 Mar; 129(3):267-76. PubMed ID: 11231454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Brabender J; Lord RV; Wickramasinghe K; Metzger R; Schneider PM; Park JM; Hölscher AH; DeMeester TR; Danenberg KD; Danenberg PV
    J Gastrointest Surg; 2002; 6(3):359-67. PubMed ID: 12022988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Brabender J; Lord RV; Danenberg KD; Metzger R; Schneider PM; Uetake H; Kawakami K; Park JM; Salonga D; Peters JH; DeMeester TR; Hölscher AH; Danenberg PV
    J Gastrointest Surg; 2001; 5(2):174-81; discussion 182. PubMed ID: 11331481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma.
    Wu GD; Beer DG; Moore JH; Orringer MB; Appelman HD; Traber PG
    Gastroenterology; 1993 Sep; 105(3):837-44. PubMed ID: 8359653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of retinoid X receptor mRNA expression in Barrett's esophagus.
    Brabender J; Lord RV; Metzger R; Park J; Salonga D; Danenberg KD; Hölscher AH; Danenberg PV; Schneider PM
    J Gastrointest Surg; 2004; 8(4):413-22. PubMed ID: 15120365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis.
    Lee OJ; Schneider-Stock R; McChesney PA; Kuester D; Roessner A; Vieth M; Moskaluk CA; El-Rifai W
    Neoplasia; 2005 Sep; 7(9):854-61. PubMed ID: 16229808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
    Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
    Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.
    Morales CP; Lee EL; Shay JW
    Cancer; 1998 Aug; 83(4):652-9. PubMed ID: 9708927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence.
    O'Farrell NJ; Feighery R; Picardo SL; Lynam-Lennon N; Biniecka M; McGarrigle SA; Phelan JJ; MacCarthy F; O'Toole D; Fox EJ; Ravi N; Reynolds JV; O'Sullivan J
    BMC Cancer; 2016 Jul; 16():497. PubMed ID: 27431913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinoma.
    Sonoda R; Naomoto Y; Shirakawa Y; Fujiwara Y; Yamatsuji T; Noma K; Tanabe S; Takaoka M; Gunduz M; Tsujigiwa H; Nagatsuka H; Ohara N; Yoshino T; Takubo K; Vieth M; Tanaka N
    Histopathology; 2010 Jul; 57(1):90-100. PubMed ID: 20653782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal differentiation and p53 gene alterations in Barrett's esophagus and esophageal adenocarcinoma.
    Moore JH; Lesser EJ; Erdody DH; Natale RB; Orringer MB; Beer DG
    Int J Cancer; 1994 Feb; 56(4):487-93. PubMed ID: 7906678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis and management of Barrett's esophagus.
    DeMeester SR; DeMeester TR
    Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.